Monoclonal anti-TNF-α suppresses graft vs host disease reactions in an in vitro human skin model
- 1 March 1994
- Vol. 6 (2), 141-146
- https://doi.org/10.1016/1043-4666(94)90035-3
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Cytokine dysregulation and acute graft-versus-host diseaseBlood, 1992
- More insights into the complex physiology of TNFImmunology Today, 1991
- Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10) [see comments]Blood, 1990
- Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.The Journal of Experimental Medicine, 1987
- A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytesJournal of Immunological Methods, 1986
- An in Vitro Predictive Test for Graft versus Host Disease in Patients with Genotypic HLA-Identical Bone Marrow TransplantsNew England Journal of Medicine, 1985